Erste Asset Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.7M | Buy |
|
|||||
|
2025
Q1 | $62.8M | Buy |
|
|||||
|
2024
Q4 | $76M | Buy |
|
|||||
|
2024
Q3 | $79.4M | Buy |
|
|||||
|
2024
Q2 | $82.4M | Sell |
|
|||||
|
2024
Q1 | $74M | Sell |
|
|||||
|
2023
Q4 | $67.7M | Buy |
|
|||||
|
2023
Q3 | $83.2M | Sell |
|
|||||
|
2023
Q2 | $82.3M | Buy |
|
|||||
|
2023
Q1 | $89.3M | Buy |
|
|||||
|
2022
Q4 | $79.5M | Sell |
|
|||||
|
2022
Q3 | $74.2M | Sell |
|
|||||
|
2022
Q2 | $58.6M | Hold |
|
|||||
|
2022
Q1 | $60.9M | Sell |
|
|||||
|
2021
Q4 | $78M | Buy |
|
|||||
|
2021
Q3 | $78.8M | Buy |
|
|||||
|
2021
Q2 | $64M | Buy |
|
|||||
|
2021
Q1 | $47.8M | Buy |
|
|||||
|
2020
Q4 | $65.3M | Buy |
|
|||||
|
2020
Q3 | $52.4M | Sell |
|
|||||
|
2020
Q2 | $64.6M | Sell |
|
|||||
|
2020
Q1 | $41.8M | Sell |
|
|||||
|
2019
Q4 | $73.6M | Buy |
|
|||||
|
2019
Q3 | $41.3M | Buy |
|
|||||
|
2019
Q2 | $78.6M | Buy |
|
|||||
|
2019
Q1 | $62.3M | Buy |
|
|||||
|
2018
Q4 | $54.8M | Buy |
|